Quantinno Capital Management LP Boosts Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Quantinno Capital Management LP raised its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 48.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 59,911 shares of the health services provider's stock after buying an additional 19,454 shares during the period. Quantinno Capital Management LP owned about 0.18% of Amedisys worth $5,439,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. increased its holdings in Amedisys by 55.1% during the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after buying an additional 124 shares during the last quarter. Xponance Inc. increased its position in Amedisys by 3.5% in the fourth quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock worth $395,000 after buying an additional 148 shares in the last quarter. Inspire Investing LLC increased its position in Amedisys by 3.6% in the fourth quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider's stock worth $400,000 after buying an additional 155 shares in the last quarter. Gamco Investors INC. ET AL raised its stake in shares of Amedisys by 0.5% in the fourth quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock worth $2,754,000 after buying an additional 159 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in shares of Amedisys by 1.2% during the 4th quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock valued at $1,375,000 after buying an additional 180 shares in the last quarter. 94.36% of the stock is owned by institutional investors.

Analysts Set New Price Targets

AMED has been the subject of several analyst reports. Stephens reissued an "equal weight" rating and issued a $101.00 target price on shares of Amedisys in a report on Tuesday, March 4th. Royal Bank of Canada reissued an "outperform" rating and issued a $100.00 price objective on shares of Amedisys in a research note on Wednesday, April 16th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Amedisys presently has a consensus rating of "Hold" and a consensus target price of $100.75.

Amedisys Price Performance

NASDAQ AMED traded up $0.00 during trading hours on Friday, reaching $93.56. The company's stock had a trading volume of 11,450 shares, compared to its average volume of 417,569. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.95. The firm's 50-day moving average price is $93.34 and its 200-day moving average price is $91.63. The company has a market capitalization of $3.07 billion, a price-to-earnings ratio of 37.15, a PEG ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.12. The company had revenue of $594.78 million during the quarter, compared to analysts' expectations of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Amedisys's quarterly revenue was up 4.1% on a year-over-year basis. During the same period last year, the company posted $1.03 earnings per share. On average, equities research analysts predict that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.